SpringWorks Therapeutics Inc (SWTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

100 WASHINGTON BOULEVARD STAMFORD, CT 06902

SpringWorks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company acquires, develops, and commercializes medicines for patients suffering various diseases and cancer. SpringWorks Therapeutics serves customers in the United States.

Data as of 2020-08-09
Market Cap1.962 Billion Shares Outstanding43.01 Million Avg 30-day Volume228.03 Thousand
P/E Ratio17.1 Dividend Yield EPS2.67
Price/Sales Price cash flow ratio Price free cash flow ratio-44.8
Book Value7.16 Price to Tangible Book6.37 Alpha0.07
Short Interest Ratio % Short Interest to Float R-squared0.138217
BETA1.33637 52-week High/Low49.79 / 17.02 Stddev0.242197

Are you looking for this stock instead?

View SEC Filings from SWTX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 6 3 (0.2%)
13F Filers holding this stock: 67 25 (1.64%)
Aggregate 13F shares on 03/31/2020: 32.784 Million 19.991 Million
Aggregate 13F shares on 12/31/2019: 31.922 Million 19.223 Million
Percent change: 2.70% 3.99%
Funds creating new positions: 15 5
Funds Adding to an existing position: 23 12
Funds closing out their position: 5 1
Funds reducing their position: 18 5
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SWTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SWTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ISLAM SAQIB

0 2020-08-06 1

SQUINTO STEPHEN P

  • Director
0 2020-08-06 2

FUHRMAN ALAN

  • Director
0 2020-08-06 1

PICHL DANIEL CHIEF PEOPLE OFFICER

  • Officer
0 2020-08-03 2

LEWIS-HALL FREDA C

  • Director
8,472 2020-07-23 1

LYNCH DANIEL

  • Director
127,904 2020-06-24 1

SCHWARTZ JEFFREY LAWRENCE

  • Director
  • 10% Owner
0 2020-05-20 1

HAMBLETON JULIE

  • Director
0 2020-05-20 2

SMITH L. MARY SEE REMARKS

  • Officer
0 2020-03-02 1

FRANCIS PERIER I JR CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-02 1

RENSTRUP JENS CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-02 1

EDRIS BADREDDIN CHIEF BUSINESS OFFICER

  • Officer
0 2020-03-02 1

WEINSTEIN HERSCHEL S GENERAL COUNSEL AND SECRETARY

  • Officer
0 2020-02-03 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PICHL DANIEL - Officer CHIEF PEOPLE OFFICER

2020-08-03 A 75,000 a 75,000 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments